Page last updated: 2024-08-23

nimustine and Acute Lymphoid Leukemia

nimustine has been researched along with Acute Lymphoid Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumabe, T; Nagamatsu, K; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M1
Ogawa, M; Ueda, T; Yamauchi, T1

Other Studies

2 other study(ies) available for nimustine and Acute Lymphoid Leukemia

ArticleYear
Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.
    Journal of neurosurgery. Pediatrics, 2011, Volume: 7, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Brain Stem Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Convection; Cranial Irradiation; Drug Delivery Systems; Follow-Up Studies; Glioblastoma; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Nimustine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stereotaxic Techniques

2011
Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Molecular pharmacology, 2008, Volume: 74, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cadmium Chloride; Carmustine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Dacarbazine; DNA Mismatch Repair; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Guanine; Humans; Hydroxylamines; Nimustine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide

2008